ICU Medical/ICUI

$101.14

-3.58%
-
1D1W1MYTD1YMAX

About ICU Medical

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.

Ticker

ICUI

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Vivek Jain

Employees

14,000

Headquarters

San clemente, United States

ICU Medical Metrics

BasicAdvanced
$2.6B
Market cap
-
P/E ratio
-$2.46
EPS
0.73
Beta
-
Dividend rate
$2.6B
0.73209
$196.57
$78.28
244K
2.608
1.086
75.836
78.342
52.643
0.48%
-1.35%
-2.85%
-1.51%
1.132
1.236
34.105
-2.1%
-27.79%
21.13%

What the Analysts think about ICU Medical

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 3 analysts.
34.47% upside
High $137.00
Low $135.00
$101.14
Current price
$136.00
Average price target

ICU Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-6.95% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$567M
-3.61%
Net income
-$39M
130.41%
Profit margin
-6.95%
139.66%

ICU Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 17.07%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.88
$1.57
$1.57
$0.96
-
Expected
$1.60
$1.39
$1.19
$0.82
$1.00
Surprise
17.5%
13.36%
31.66%
17.07%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for ICU Medical stock?

ICU Medical (ICUI) has a market cap of $2.6B as of May 30, 2024.

What is the P/E ratio for ICU Medical stock?

The price to earnings (P/E) ratio for ICU Medical (ICUI) stock is 0 as of May 30, 2024.

Does ICU Medical stock pay dividends?

No, ICU Medical (ICUI) stock does not pay dividends to its shareholders as of May 30, 2024.

When is the next ICU Medical dividend payment date?

ICU Medical (ICUI) stock does not pay dividends to its shareholders.

What is the beta indicator for ICU Medical?

ICU Medical (ICUI) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the ICU Medical stock price target?

The target price for ICU Medical (ICUI) stock is $136, which is 34.47% above the current price of $101.14. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell ICU Medical stock

Buy or sell ICU Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing